Scientists have discovered a gut microbe and its metabolites that can naturally regulate blood sugar levels and sugar ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Mounjaro is a prescription injection, often used off-label for weight loss, that is administered under the skin to patients struggling with obesity and weight loss. Off-label means that the actual use ...

A decision is expected in the fourth quarter of 2025.

Kyle Richards’ daughter Sophia Umansky detailed the unexpected side effects that surfaced four months after she started ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Cigna, which comprises the Evernorth Health Services division and the Cigna Healthcare insurance business, reported a 19% ...

"Ozempic feet" is a side effect of taking GLP-1 medications for weight loss. Here's why it happens and what you can do.